Economy

Bank of Hawaii Has $6572000 Position in GlaxoSmithKline PLC (GSK)

Shares of GlaxoSmithKline plc (LON:GSK) have been assigned a consensus recommendation of "Hold" from the twenty-two ratings firms that are now covering the stock, Marketbeat reports. Zacks Investment Research lowered GlaxoSmithKline from a "buy" rating to a "hold" rating in a research note on Wednesday.

Minerva Advisors Llc holds 0.3% of its portfolio in Rand Logistics, Inc. for 1.79 million shares. Bogart Wealth LLC's holdings in GlaxoSmithKline were worth $1,436,000 at the end of the most recent quarter.

GSK has been the topic of a number of other reports. Finally, Neuberger Berman Group LLC lifted its position in shares of GlaxoSmithKline by 1.6% in the third quarter. Wealthcare Advisory Partners LLC now owns 3,520 shares of the pharmaceutical company's stock worth $143,000 after purchasing an additional 3,351 shares in the last quarter. FMR LLC increased its stake in GlaxoSmithKline by 5.9% in the 2nd quarter. Over the last ninety days, insiders acquired 1,577 shares of company stock worth $2,400,086. Neuberger Berman Group LLC now owns 991,683 shares of the pharmaceutical company's stock worth $40,262,000 after purchasing an additional 15,660 shares in the last quarter. Florida-based Raymond James And Associates has invested 0.01% in Voya Financial, Inc. Whittier Trust Co. now owns 5,058 shares of the pharmaceutical company's stock worth $219,000 after buying an additional 425 shares during the period. Finally, Seatown Holdings Pte. While, the analyst predicted that the company could provide an EPS of $0.83/share. The stock has "Buy" rating by UBS on Monday, November 27.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 10.00% of the company's stock.

Several research firms have recently weighed in on GSK. Piperjaffray initiated the shares of GSK in report on Friday, September 23 with "Overweight" rating. The stock of GlaxoSmithKline plc (NYSE:GSK) earned "Buy" rating by Argus Research on Monday, December 7. Cowen set a $38.00 price target on shares of GlaxoSmithKline and gave the stock a "hold" rating in a research note on Monday, December 11th. The stock has "Buy" rating by Jefferies on Friday, June 16.

Among 17 analysts covering GlaxoSmithKline (NYSE:GSK), 7 have Buy rating, 1 Sell and 9 Hold. The mean target price as estimated by the analysts for the company has been recorded at $42.72. Deutsche Bank AG reissued a "hold" rating on shares of GlaxoSmithKline PLC in a research note on Thursday, October 27th. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 2.96. Glaxosmithkline Plc now has $84.98 billion valuation. The company has market cap of $85.38 billion. The ex-dividend date is Thursday, November 9th. This represents a $2.01 dividend on an annualized basis and a yield of 5.54%. This is a positive change from GlaxoSmithKline's previous quarterly dividend of $0.49. GlaxoSmithKline's payout ratio is 154.26%.

ILLEGAL ACTIVITY WARNING: This report was first reported by BBNS and is the sole property of of BBNS. If you are reading this piece on another site, it was stolen and reposted in violation of USA and global copyright & trademark legislation. About 5.29M shares traded.

GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. The company operates in the Healthcare sector with a market capitalization of 87.1 Million. The firm offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV.

Hedge funds and other institutional investors have recently modified their holdings of the business.



Like this

loading...
loading...

Latest


14 January 2018
Caterpillar Inc. (CAT) Shares Sold by Adams Asset Advisors LLC
Insiders have sold a total of 52,989 shares of company stock worth $7,235,850 over the last 90 days. (NYSE:OI) for 34,058 shares. Wall Street is only getting more bullish on the stock, with 11 of analysts who cover CAT having a buy-equivalent rating.

14 January 2018
KAR Auction Services (NYSE:KAR) Given Daily Media Sentiment Score of 0.16
KAR Auction Services had a return on equity of 22.37% and a net margin of 6.94%. (NYSE:DST) on Friday, August 14 to "Sell" rating. Also, EVP Benjamin Skuy sold 12,000 shares of the business's stock in a transaction that occurred on Wednesday, November 22nd.

14 January 2018
EPS for Devon Energy Corporation (DVN) Expected At $0.58
After $1.50 actual EPS reported by Union Pacific Corporation for the previous quarter, Wall Street now forecasts 2.00% EPS growth. The energy company reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.39 by $0.07.

14 January 2018
Canadiens' Danault exits game after being hit in head by Chara shot
Chara, who has one of the hardest shots in the National Hockey League , looked on in concern as trainers attended to Danault. Danault remained down for quite some time before ultimately being stretchered off of the Bell Centre ice.

14 January 2018
Second five-point game of season
He then got his 15th of the season when he finished his own rebound on another Islanders odd-man rush at 4:11, making it 4-1. The Rangers got one back nine minutes into the third period thanks to Mika Zibanejad who netted his 14th goal of the season.

14 January 2018
Ciechanover Sells 2200 Shares of Atara Biotherapeutics Inc (ATRA) Stock
Moreover, Metropolitan Life Ins Com Ny has 0% invested in Atara Biotherapeutics, Inc . (NASDAQ: ATRA ) for 30,941 shares. Bridger Limited Liability Corporation invested in 1.64% or 1.65M shares. $64,438 worth of Atara Biotherapeutics, Inc .

14 January 2018
Warriors G will play Saturday vs. Raptors
The Warriors guard will make his return Saturday when Golden State visits the Raptors , the team announced prior to the matchup. Riding the wave: Toronto enters Saturday's game coming off a dominant 133-99 victory over the Cleveland Cavaliers on Thursday.

14 January 2018
Bank of America (NYSE:BAC) PT Raised to $35.00
David Rodriguez increased its stake in Bank Amer Corp (BAC) by 55.5% based on its latest 2017Q3 regulatory filing with the SEC. The fund owned 19,628,386 shares of the financial services provider's stock after selling 862,168 shares during the period.

14 January 2018
Sentiment Report: Eog Resources Inc (NYSE:EOG)
The energy exploration company reported $0.19 EPS for the quarter, beating the Zacks' consensus estimate of $0.12 by $0.07. Appleton Partners Inc sold 5,140 shares as the company's stock rose 5.51% with the market. (NYSE:EOG) for 199,570 shares.

14 January 2018
Sandy Spring Bancorp (SASR) Upgraded to Hold by BidaskClub
Finally, Bessemer Group Inc. acquired a new stake in shares of Sandy Spring Bancorp during the fourth quarter valued at $390,000. The stock of Brookfield Infrastructure Partners L.P. (NYSE:BIP) has "Neutral" rating given on Monday, September 19 by Citigroup.